| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| RELMADA THERAPEUTICS, INC. | Director | Stock Appreciation Rights | 164,000 | 12 Dec 2025 | Direct | ||
| RELMADA THERAPEUTICS, INC. | Director | Stock Option (right to buy) | 100,000 | 26 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RLMD | RELMADA THERAPEUTICS, INC. | 12 Dec 2025 | 1 | $0 | 4 | Director | 16 Dec 2025, 09:29 |
| RLMD | RELMADA THERAPEUTICS, INC. | 26 Jun 2025 | 1 | $0 | 4 | Director | 30 Jun 2025, 19:28 |
| RLMD | RELMADA THERAPEUTICS, INC. | 24 May 2024 | 2 | $0 | 4 | Director | 29 May 2024, 21:24 |
| RLMD | RELMADA THERAPEUTICS, INC. | 15 Dec 2023 | 1 | $0 | 4 | Director | 19 Dec 2023, 17:27 |
| RLMD | RELMADA THERAPEUTICS, INC. | 25 May 2023 | 1 | $0 | 4 | Director | 30 May 2023, 17:06 |
| RLMD | RELMADA THERAPEUTICS, INC. | 12 Jan 2023 | 0 | $0 | 3 | Director | 13 Jan 2023, 19:41 |